164 results
Page 4 of 9
8-K
EX-99.1
oa85mw1vu48gilemcl
2 Aug 12
Discovery Labs Reports Second Quarter 2012 Financial Results
12:00am
424B5
ctfs jt66jm9j9
19 Mar 12
Prospectus supplement for primary offering
12:00am
424B5
6qqkie92
15 Mar 12
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
0udj7hy7
7 Mar 12
Discovery Labs Announces FDA Approval of SURFAXIN® (lucinactant) for Prevention of Respiratory Distress Syndrome
12:00am
424B5
8u0764q93r2 rvlak
15 Dec 11
Prospectus supplement for primary offering
12:00am
8-K
ycd7wfehz
29 Jul 11
Other Events
12:00am
8-K
EX-99.1
6ko2mail4szwya
1 Jun 11
Other Events
12:00am
8-K
EX-99.1
bw9n27 d859kgfkr
11 May 11
Results of Operations and Financial Condition
12:00am
424B5
qqth5r6yr ef09
17 Feb 11
Prospectus supplement for primary offering
12:00am
424B5
byg05uiz6
15 Feb 11
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
7j84huxu oiw5py0j
9 Feb 11
Other Events
12:00am